{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:37:57Z","timestamp":1793050677335,"version":"4.5.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["P01AG015379"],"award-info":[{"award-number":["P01AG015379"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS136122"],"award-info":[{"award-number":["R01NS136122"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RF1AG006173"],"award-info":[{"award-number":["RF1AG006173"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P01AG015379"],"award-info":[{"award-number":["P01AG015379"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.celrep.2026.117599","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T09:36:43Z","timestamp":1782812203000},"page":"117599","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Immunotherapy with B28, an antibody to A\u03b2 oligomers, potently decreases amyloid plaques, microgliosis, and memory decline in APP knock-in mice"],"prefix":"10.1016","volume":"45","author":[{"given":"Ting","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi Ran","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaomin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Pierre","family":"Bellier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youqi","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna E.","family":"Francis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Stern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanxue","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beth L.","family":"Ostaszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trebor L.","family":"Lawton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Pradier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Reczek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia A.","family":"Lemere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic M.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8846-9767","authenticated-orcid":false,"given":"Dennis J.","family":"Selkoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2026.117599_bib1","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S0006-291X(84)80190-4","article-title":"Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein","volume":"120","author":"Glenner","year":"1984","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.celrep.2026.117599_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in Early Alzheimer's Disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celrep.2026.117599_bib4","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.celrep.2026.117599_bib5","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.celrep.2026.117599_bib6","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1093\/brain\/awad188","article-title":"Amyloid-related imaging abnormalities (ARIA): radiological, biological and clinical characteristics","volume":"146","author":"Hampel","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.celrep.2026.117599_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1137069","article-title":"Large-scale antibody immune response mapping of splenic B cells and bone marrow plasma cells in a transgenic mouse model","volume":"14","author":"Pan","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.celrep.2026.117599_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0235815","article-title":"Complementary epitopes and favorable developability of monoclonal anti-LAMP1 antibodies generated using two transgenic animal platforms","volume":"15","author":"Cameron","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.celrep.2026.117599_bib9","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/eji.202149374","article-title":"A pair of noncompeting neutralizing human monoclonal antibodies protecting from disease in a SARS-CoV-2 infection model","volume":"52","author":"Peter","year":"2022","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.celrep.2026.117599_bib10","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1038\/s41467-018-05068-w","article-title":"An in vitro paradigm to assess potential anti-Abeta antibodies for Alzheimer's disease","volume":"9","author":"Jin","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2026.117599_bib11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s40478-023-01511-2","article-title":"Learnings about Abeta from human brain recommend the use of a live-neuron bioassay for the discovery of next generation Alzheimer's disease immunotherapeutics","volume":"11","author":"Wang","year":"2023","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.celrep.2026.117599_bib12","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.1093\/brain\/awac023","article-title":"A calcium-sensitive antibody isolates soluble amyloid-beta aggregates and fibrils from Alzheimer's disease brain","volume":"145","author":"Stern","year":"2022","journal-title":"Brain"},{"key":"10.1016\/j.celrep.2026.117599_bib13","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12868-018-0446-8","article-title":"Cognitive and emotional alterations in App knock-in mouse models of Abeta amyloidosis","volume":"19","author":"Sakakibara","year":"2018","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.celrep.2026.117599_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.neures.2025.104959","article-title":"A decade progress in the phenotyping of App(NL-G-F) knock-in mouse model of Alzheimer's disease","volume":"220","author":"Manabe","year":"2025","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.celrep.2026.117599_bib15","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nn.3697","article-title":"Single App knock-in mouse models of Alzheimer's disease","volume":"17","author":"Saito","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.celrep.2026.117599_bib16","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jneumeth.2008.09.002","article-title":"Characterisation of two antibodies to oligomeric Abeta and their use in ELISAs on human brain tissue homogenates","volume":"176","author":"van Helmond","year":"2009","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.celrep.2026.117599_bib17","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/alz.12457","article-title":"An ultra-sensitive immunoassay detects and quantifies soluble Abeta oligomers in human plasma","volume":"18","author":"Liu","year":"2022","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.celrep.2026.117599_bib18","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13195-025-01802-x","article-title":"An improved immunoassay detects Abeta oligomers in human biofluids: their CSF levels rise with tau and phosphotau levels","volume":"17","author":"Yang","year":"2025","journal-title":"Alz. Res. Therapy"},{"key":"10.1016\/j.celrep.2026.117599_bib19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00401-018-1846-7","article-title":"Diffusible, highly bioactive oligomers represent a critical minority of soluble Abeta in Alzheimer's disease brain","volume":"136","author":"Hong","year":"2018","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.celrep.2026.117599_bib20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13195-015-0100-y","article-title":"A highly sensitive novel immunoassay specifically detects low levels of soluble Abeta oligomers in human cerebrospinal fluid","volume":"7","author":"Yang","year":"2015","journal-title":"Alz. Res. Therapy"},{"key":"10.1016\/j.celrep.2026.117599_bib21","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.nbd.2015.07.008","article-title":"Anti-Abeta antibodies incapable of reducing cerebral Abeta oligomers fail to attenuate spatial reference memory deficits in J20 mice","volume":"82","author":"Mably","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.celrep.2026.117599_bib22","doi-asserted-by":"crossref","first-page":"6448","DOI":"10.1073\/pnas.95.11.6448","article-title":"Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins","volume":"95","author":"Lambert","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2026.117599_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/alz.71350","article-title":"Anti-amyloid antibody equilibrium binding to Abeta aggregates from human Alzheimer's disease brain","volume":"22","author":"Bj\u00f8rnholm","year":"2026","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.celrep.2026.117599_bib24","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13024-021-00457-0","article-title":"Knock-in models related to Alzheimer's disease: synaptic transmission, plaques and the role of microglia","volume":"16","author":"Benitez","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.celrep.2026.117599_bib25","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13195-020-00667-6","article-title":"The two faces of synaptic failure in App(NL-G-F) knock-in mice","volume":"12","author":"Latif-Hernandez","year":"2020","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.celrep.2026.117599_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.106375","article-title":"INPP5D modulates TREM2 loss-of-function phenotypes in a beta-amyloidosis mouse model","volume":"26","author":"Iguchi","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.celrep.2026.117599_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.878303","article-title":"Autophagy Impairment in App Knock-in Alzheimer's Model Mice","volume":"14","author":"Jiang","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.celrep.2026.117599_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/alz.70194","article-title":"Inhibition of hippocampal mossy fiber plasticity and episodic memory by human Abeta oligomers is prevented by enhancing cAMP signaling in Alzheimer's mice","volume":"21","author":"Jin","year":"2025","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.celrep.2026.117599_bib29","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jalz.2012.11.005","article-title":"New ELISAs with high specificity for soluble oligomers of amyloid beta-protein detect natural Abeta oligomers in human brain but not CSF","volume":"9","author":"Yang","year":"2013","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.celrep.2026.117599_bib30","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/ana.27175","article-title":"Lecanemab-Associated Amyloid-beta Protofibril in Cerebrospinal Fluid Correlates with Biomarkers of Neurodegeneration in Alzheimer's Disease","volume":"97","author":"Noguchi-Shinohara","year":"2025","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.celrep.2026.117599_bib31","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.jalz.2015.01.005","article-title":"The aqueous phase of Alzheimer's disease brain contains assemblies built from approximately 4 and approximately 7 kDa Abeta species","volume":"11","author":"Mc Donald","year":"2015","journal-title":"Alzheimer's Dement."},{"key":"10.1016\/j.celrep.2026.117599_bib32","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/j.neuron.2023.04.007","article-title":"Abundant Abeta fibrils in ultracentrifugal supernatants of aqueous extracts from Alzheimer's disease brains","volume":"111","author":"Stern","year":"2023","journal-title":"Neuron"},{"key":"10.1016\/j.celrep.2026.117599_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2023.1108715","article-title":"Methods for the isolation and analysis of Abeta from postmortem brain","volume":"17","author":"Hong","year":"2023","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.celrep.2026.117599_bib34","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.bbrc.2021.02.081","article-title":"Identification of highest neurotoxic amyloid-beta plaque type showing reduced contact with astrocytes","volume":"549","author":"Mitsubori","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.celrep.2026.117599_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.101159","article-title":"Spreading of Alzheimer tau seeds is enhanced by aging and template matching with limited impact of amyloid-beta","volume":"297","author":"Nies","year":"2021","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.celrep.2026.117599_bib36","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1097\/NEN.0b013e3182933788","article-title":"Differential relationships of reactive astrocytes and microglia to fibrillar amyloid deposits in Alzheimer disease","volume":"72","author":"Serrano-Pozo","year":"2013","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.celrep.2026.117599_bib37","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s12974-018-1180-y","article-title":"Neuroinflammation is increased in the parietal cortex of atypical Alzheimer's disease","volume":"15","author":"Boon","year":"2018","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.celrep.2026.117599_bib38","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12974-016-0601-z","article-title":"Microglial immunophenotype in dementia with Alzheimer's pathology","volume":"13","author":"Minett","year":"2016","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.celrep.2026.117599_bib39","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.3390\/cells12182258","article-title":"Morphofunctional Investigation in a Transgenic Mouse Model of Alzheimer's Disease: Non-Reactive Astrocytes Are Involved in Abeta Load and Reactive Astrocytes in Plaque Build-Up","volume":"12","author":"Lana","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.celrep.2026.117599_bib40","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00401-009-0622-0","article-title":"Microglia: biology and pathology","volume":"119","author":"Graeber","year":"2010","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.celrep.2026.117599_bib41","doi-asserted-by":"crossref","first-page":"198","DOI":"10.3389\/fncel.2020.00198","article-title":"Overview of General and Discriminating Markers of Differential Microglia Phenotypes","volume":"14","author":"Jurga","year":"2020","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.celrep.2026.117599_bib42","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcae218","article-title":"Associations of amyloid-beta oligomers and plaques with neuropathology in the App (NL-G-F) mouse","volume":"6","author":"Tang","year":"2024","journal-title":"Brain Commun."},{"key":"10.1016\/j.celrep.2026.117599_bib43","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3233\/JAD-2009-1045","article-title":"Abeta-dependent Inhibition of LTP in different intracortical circuits of the visual cortex: the role of RAGE","volume":"17","author":"Origlia","year":"2009","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.celrep.2026.117599_bib44","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/nm1782","article-title":"Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory","volume":"14","author":"Shankar","year":"2008","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2026.117599_bib45","doi-asserted-by":"crossref","first-page":"6627","DOI":"10.1523\/JNEUROSCI.0203-11.2011","article-title":"Soluble Abeta oligomers inhibit long-term potentiation through a mechanism involving excessive activation of extrasynaptic NR2B-containing NMDA receptors","volume":"31","author":"Li","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.celrep.2026.117599_bib46","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ana.410420114","article-title":"Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease","volume":"42","author":"Minoshima","year":"1997","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.celrep.2026.117599_bib47","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S1474-4422(11)70289-7","article-title":"Posterior cortical atrophy","volume":"11","author":"Crutch","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.celrep.2026.117599_bib48","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.neuron.2009.05.012","article-title":"Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake","volume":"62","author":"Li","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.celrep.2026.117599_bib49","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1021\/cn500105p","article-title":"New mouse model of Alzheimer's","volume":"5","author":"Nilsson","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.celrep.2026.117599_bib50","doi-asserted-by":"crossref","first-page":"6264","DOI":"10.1038\/s41598-018-24657-9","article-title":"Spatial reversal learning defect coincides with hypersynchronous telencephalic BOLD functional connectivity in APP(NL-F\/NL-F) knock-in mice","volume":"8","author":"Shah","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.celrep.2026.117599_bib51","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.bbr.2017.11.017","article-title":"Subtle behavioral changes and increased prefrontal-hippocampal network synchronicity in APP(NL-G-F) mice before prominent plaque deposition","volume":"364","author":"Latif-Hernandez","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.celrep.2026.117599_bib52","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.neurobiolaging.2018.10.026","article-title":"Age-dependent behavioral and biochemical characterization of single APP knock-in mouse (APP(NL-G-F\/NL-G-F)) model of Alzheimer's disease","volume":"75","author":"Mehla","year":"2019","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.celrep.2026.117599_bib53","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13024-024-00758-0","article-title":"Amyloid-beta (Abeta) immunotherapy induced microhemorrhages are linked to vascular inflammation and cerebrovascular damage in a mouse model of Alzheimer's disease","volume":"19","author":"Taylor","year":"2024","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.celrep.2026.117599_bib54","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13024-023-00649-w","article-title":"Amyloid-beta (Abeta) immunotherapy induced microhemorrhages are associated with activated perivascular macrophages and peripheral monocyte recruitment in Alzheimer's disease mice","volume":"18","author":"Taylor","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.celrep.2026.117599_bib55","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1523\/JNEUROSCI.4337-04.2005","article-title":"Exacerbation of cerebral amyloid angiopathy-associated microhemorrhage in amyloid precursor protein transgenic mice by immunotherapy is dependent on antibody recognition of deposited forms of amyloid beta","volume":"25","author":"Racke","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.celrep.2026.117599_bib56","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd7522","article-title":"APOE immunotherapy reduces cerebral amyloid angiopathy and amyloid plaques while improving cerebrovascular function","volume":"13","author":"Xiong","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.celrep.2026.117599_bib57","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13024-025-00836-x","article-title":"Mouse models of Anti-Abeta immunotherapies","volume":"20","author":"Pikus","year":"2025","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.celrep.2026.117599_bib58","doi-asserted-by":"crossref","DOI":"10.1080\/19420862.2023.2261509","article-title":"Delivery of the Brainshuttle amyloid-beta antibody fusion trontinemab to non-human primate brain and projected efficacious dose regimens in humans","volume":"15","author":"Grimm","year":"2023","journal-title":"mAbs"},{"key":"10.1016\/j.celrep.2026.117599_bib59","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1002\/ana.78196","article-title":"Novel Monoclonal Antibody Detects Small Abeta Oligomers More Sensitively Than Lecanemab in Alzheimer's Disease CSF, Serum and Culture Media","volume":"99","author":"Xu","year":"2026","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.celrep.2026.117599_bib60","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.neuron.2012.10.029","article-title":"A plaque-specific antibody clears existing beta-amyloid plaques in Alzheimer's disease mice","volume":"76","author":"Demattos","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.celrep.2026.117599_bib61","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13195-018-0447-y","article-title":"SAR228810: an antibody for protofibrillar amyloid beta peptide designed to reduce the risk of amyloid-related imaging abnormalities (ARIA)","volume":"10","author":"Pradier","year":"2018","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.celrep.2026.117599_bib62","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1523\/JNEUROSCI.14-03-01634.1994","article-title":"Hebbian synapses in visual cortex","volume":"14","author":"Kirkwood","year":"1994","journal-title":"J. Neurosci."},{"key":"10.1016\/j.celrep.2026.117599_bib63","doi-asserted-by":"crossref","first-page":"11947","DOI":"10.1523\/JNEUROSCI.2009-17.2017","article-title":"Human Brain-Derived Abeta Oligomers Bind to Synapses and Disrupt Synaptic Activity in a Manner That Requires APP","volume":"37","author":"Wang","year":"2017","journal-title":"J. Neurosci."},{"key":"10.1016\/j.celrep.2026.117599_bib64","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.neuron.2013.05.029","article-title":"Rapid single-step induction of functional neurons from human pluripotent stem cells","volume":"78","author":"Zhang","year":"2013","journal-title":"Neuron"},{"key":"10.1016\/j.celrep.2026.117599_bib65","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ymeth.2015.11.019","article-title":"Rapid Ngn2-induction of excitatory neurons from hiPSC-derived neural progenitor cells","volume":"101","author":"Ho","year":"2016","journal-title":"Methods"}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124726006777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211124726006777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:19:28Z","timestamp":1793049568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211124726006777"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":64,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2211124726006777"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2026.117599","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunotherapy with B28, an antibody to A\u03b2 oligomers, potently decreases amyloid plaques, microgliosis, and memory decline in APP knock-in mice","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2026.117599","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117599"}}